Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 9Neoplasms 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Multiple Myeloma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Sarcoma 2Rectal Neoplasms 2Radiation Injuries 2Prostatic Neoplasms 2Preleukemia 2Precancerous Conditions 2Osteosarcoma 2Neoplasms by Histologic Type 2Nasopharyngeal Carcinoma 2Myelodysplastic Syndromes 2Multiple Chronic Conditions 2Melanoma 2Lymphoproliferative Disorders 2Lymphatic Diseases 2Lung Neoplasms 2Leukemia, Myeloid 2Leukemia, Lymphoid 2Leukemia, Biphenotypic, Acute 2

Interventions

pembrolizumab 92Gemcitabine 56Nivolumab 50Cisplatin 39atezolizumab 37Carboplatin 30avelumab 29enfortumab vedotin 26Docetaxel 23Magnetic Resonance Spectroscopy 19Mitomycin 17Ipilimumab 17Paclitaxel 16Specimen Handling 14durvalumab 11toripalimab 10sacituzumab govitecan 10Pemetrexed 10cabozantinib 9Taxes 8vinflunine 7Cyclophosphamide 7tislelizumab 6Injections 6Bevacizumab 6pemigatinib 5fludarabine 5disitamab vedotin 5Standard of Care 5Radiosurgery 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Transitional Cell × Patient Reported Outcome Measures × Clear all
NCT04146064 2026-05-08

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

University Health Network, Toronto

Completed
190 enrolled
DermatologicGenitourinaryHead & Neck

Carcinoma, Transitional Cell, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡